Cristian Massacesi: How diseases and treatments may affect different populations
Cristian Massacesi shared a post on LinkedIn:
“As Chief Medical Officer, I’ve seen firsthand how diversity in clinical trials is important to understanding how diseases and treatments may affect different populations.
Learn how AstraZeneca is committed to sustainable science and how we’re ensuring that our clinical trials represent the diversity of the communities we serve.
For more information click here.”
Dr. Cristian Massacesi, is a medical oncologist with over 20 years of experience in drug development. Currently he serves as the Chief Medical Officer at AstraZeneca. At AstraZeneca, he holds the position of Oncology Chief Development Officer, leading the company’s late-stage Oncology portfolio comprising 13 innovative medicines and immunotherapies. In this role, he directs approximately 150 clinical studies across various indications, concentrating on AstraZeneca’s core disease areas such as breast, lung, gastrointestinal, genitourinary, and gynecological cancers.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023